These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22028401)

  • 1. Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007.
    Schlichting JA; Soliman AS; Schairer C; Banerjee M; Rozek LS; Schottenfeld D; Harford JB; Merajver SD
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):155-65. PubMed ID: 22028401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.
    Schlichting JA; Soliman AS; Schairer C; Schottenfeld D; Merajver SD
    Breast Cancer Res Treat; 2012 Aug; 134(3):1257-68. PubMed ID: 22733221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
    Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD
    Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory and other breast cancer incidence rate trends by estrogen receptor status in the Surveillance, Epidemiology, and End Results database (2001-2015).
    Aurit SJ; Devesa SS; Soliman AS; Schairer C
    Breast Cancer Res Treat; 2019 Jun; 175(3):755-764. PubMed ID: 30915662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geospatial Analysis of Inflammatory Breast Cancer and Associated Community Characteristics in the United States.
    Scott L; Mobley LR; Il'yasova D
    Int J Environ Res Public Health; 2017 Apr; 14(4):. PubMed ID: 28398259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What can we learn from the age- and race/ethnicity- specific rates of inflammatory breast carcinoma?
    Il'yasova D; Siamakpour-Reihani S; Akushevich I; Akushevich L; Spector N; Schildkraut J
    Breast Cancer Res Treat; 2011 Nov; 130(2):691-7. PubMed ID: 21850396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial/ethnic disparities in inflammatory breast cancer survival in the Michigan Cancer Surveillance Program.
    Gudina AT; Copeland G; Soliman AS; Hirko KA
    Breast Cancer Res Treat; 2019 Feb; 173(3):693-699. PubMed ID: 30406365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992.
    Chang S; Parker SL; Pham T; Buzdar AU; Hursting SD
    Cancer; 1998 Jun; 82(12):2366-72. PubMed ID: 9635529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009.
    Hirko KA; Soliman AS; Banerjee M; Ruterbusch J; Harford JB; Merajver SD; Schwartz K
    Breast J; 2014; 20(2):185-91. PubMed ID: 24372839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
    Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
    BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer.
    Schairer C; Brown LM; Mai PL
    Breast Cancer Res Treat; 2011 Aug; 129(1):117-24. PubMed ID: 21390499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing inflammatory breast cancer among Arab Americans in the California, Detroit and New Jersey Surveillance, Epidemiology and End Results (SEER) registries (1988-2008).
    Hirko KA; Soliman AS; Banerjee M; Ruterbusch J; Harford JB; Chamberlain RM; Graff JJ; Merajver SD; Schwartz K
    Springerplus; 2013 Dec; 2(1):3. PubMed ID: 23420611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of inflammatory breast cancer in women, 1992-2009, United States.
    Goldner B; Behrendt CE; Schoellhammer HF; Lee B; Chen SL
    Ann Surg Oncol; 2014 Apr; 21(4):1267-70. PubMed ID: 24366421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database.
    Abraham HG; Xia Y; Mukherjee B; Merajver SD
    Breast Cancer Res Treat; 2021 Jan; 185(1):229-238. PubMed ID: 33033965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for inflammatory breast cancer and other invasive breast cancers.
    Schairer C; Li Y; Frawley P; Graubard BI; Wellman RD; Buist DS; Kerlikowske K; Onega TL; Anderson WF; Miglioretti DL
    J Natl Cancer Inst; 2013 Sep; 105(18):1373-84. PubMed ID: 24046390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.
    Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
    Cancer; 2011 May; 117(9):1819-26. PubMed ID: 21509759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for inflammatory and non-inflammatory breast cancer in North Africa.
    Schairer C; Hablas A; Eldein IAS; Gaafar R; Rais H; Mezlini A; Ayed FB; Ayoub WB; Benider A; Tahri A; Khouchani M; Aboulazm D; Karkouri M; Eissa S; Bastawisy AE; Yehia M; Gadalla SM; Swain SM; Merajver SD; Brown LM; Pfeiffer RM; Soliman AS
    Breast Cancer Res Treat; 2020 Nov; 184(2):543-558. PubMed ID: 32876910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinoma: distinct clinicopathologic entities?
    Anderson WF; Chu KC; Chang S
    J Clin Oncol; 2003 Jun; 21(12):2254-9. PubMed ID: 12805323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
    Fouad TM; Kogawa T; Liu DD; Shen Y; Masuda H; El-Zein R; Woodward WA; Chavez-MacGregor M; Alvarez RH; Arun B; Lucci A; Krishnamurthy S; Babiera G; Buchholz TA; Valero V; Ueno NT
    Breast Cancer Res Treat; 2015 Jul; 152(2):407-16. PubMed ID: 26017070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.